CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $179,000 | -45.3% | 67,211 | -11.0% | 0.00% | -50.0% |
| Q4 2021 | $327,000 | -19.5% | 75,513 | -5.4% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | -25.1% | 79,853 | -6.7% | 0.00% | -20.0% |
| Q2 2021 | $542,000 | -16.1% | 85,629 | +2.4% | 0.01% | -16.7% |
| Q1 2021 | $646,000 | +18.1% | 83,629 | +0.2% | 0.01% | 0.0% |
| Q4 2020 | $547,000 | -13.7% | 83,493 | +1.1% | 0.01% | -40.0% |
| Q1 2020 | $634,000 | -17.2% | 82,601 | -10.4% | 0.01% | +66.7% |
| Q4 2019 | $766,000 | – | 92,233 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |